ZIPSCRIPT Trademark

Trademark Overview

On Thursday, June 20, 2024, a trademark application was filed for ZIPSCRIPT with the United States Patent and Trademark Office. The USPTO has given the ZIPSCRIPT trademark a serial number of 98610161. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, February 13, 2025. This trademark is owned by QIAGEN Beverly, LLC. The ZIPSCRIPT trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Diagnostic preparations for medical and veterinary purposes, namely, diagnostics preparations for the marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and analysis of biopolymers, namely, nucleic acids; diagnostic reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning for medical or veterinary purposes; chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, namely, reagents, enzymes and buffer solutions for the marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and analysis of biopolymers, namely, nucleic acids; diagnostic kits comprised of preparations for medical and veterinary diagnostic purposes, namely, preparations for marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and analysis of biopolymers, namely, nucleic acids; diagnostic kits containing reagents, enzymes and buffer so...

Chemical, biochemical and biotechnological diagnostic preparations for scientific purposes, namely, buffer solutions for the marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning; chemical test kits for laboratory or research use featuring chemicals for the marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and analysis of biopolymers, in particular nucleic acids, in particular comprising reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning
zipscript

General Information

Serial Number98610161
Word MarkZIPSCRIPT
Filing DateThursday, June 20, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, February 13, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 4, 2025

Trademark Statements

Goods and ServicesDiagnostic preparations for medical and veterinary purposes, namely, diagnostics preparations for the marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and analysis of biopolymers, namely, nucleic acids; diagnostic reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning for medical or veterinary purposes; chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, namely, reagents, enzymes and buffer solutions for the marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and analysis of biopolymers, namely, nucleic acids; diagnostic kits comprised of preparations for medical and veterinary diagnostic purposes, namely, preparations for marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and analysis of biopolymers, namely, nucleic acids; diagnostic kits containing reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning for medical or veterinary purposes
Pseudo MarkZIP SCRIPT
Goods and ServicesChemical, biochemical and biotechnological diagnostic preparations for scientific purposes, namely, buffer solutions for the marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning; chemical test kits for laboratory or research use featuring chemicals for the marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and analysis of biopolymers, in particular nucleic acids, in particular comprising reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, June 20, 2024
Primary Code001
First Use Anywhere DateThursday, November 9, 2017
First Use In Commerce DateThursday, November 9, 2017
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 20, 2024
Primary Code005
First Use Anywhere DateThursday, November 9, 2017
First Use In Commerce DateThursday, November 9, 2017

Trademark Owner History

Party NameQIAGEN Beverly, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBeverly, MA 01915

Trademark Events

Event DateEvent Description
Thursday, June 20, 2024NEW APPLICATION ENTERED
Monday, January 13, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 14, 2025ASSIGNED TO EXAMINER
Thursday, January 23, 2025NON-FINAL ACTION E-MAILED
Thursday, January 23, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 23, 2025NON-FINAL ACTION WRITTEN
Tuesday, February 11, 2025EXAMINER'S AMENDMENT ENTERED
Tuesday, February 11, 2025EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 11, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 11, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 11, 2025EXAMINERS AMENDMENT E-MAILED

Related Keywords

zipscript cloning nucleic reverse namely diagnostic preparations buffer analysis sequencing solutions